[Perfusion protection of ischemic liver using perfluorocarbon emulsion].

Molecular diversity of spider venom. Biochemistry (Mosc) (2009) 1.31

An ERG channel inhibitor from the scorpion Buthus eupeus. J Biol Chem (2001) 0.98

Analgesic effect of a polypeptide inhibitor of the TRPV1 receptor in noxious heat pain models. Dokl Biochem Biophys (2009) 0.94

Three-dimensional structure of toxin OSK1 from Orthochirus scrobiculosus scorpion venom. Biochemistry (1997) 0.87

[New polypeptide components from the Heteractis crispa sea anemone with analgesic activity]. Bioorg Khim (2010) 0.84

Acid-sensing ion channels and their modulators. Biochemistry (Mosc) (2014) 0.81

[Comparison of polypeptide compositions from individual Agelena orientalis spider venoms]. Bioorg Khim (2010) 0.78

[Diagnostic value of tear tests in diabetic retinopathy (a literature review)]. Klin Lab Diagn (2006) 0.77

[Polypeptide toxin from sea anemone inhibiting proton-sensitive channel ASIC3]. Bioorg Khim (2013) 0.77

The elimination peculiarities of perfluorocarbon emulsions stabilized with egg yolk phospholipid. Artif Cells Blood Substit Immobil Biotechnol (1994) 0.77

M-type K+ current inhibition by a toxin fron the scorpion Buthus eupeus. FEBS Lett (1996) 0.77

A novel cysteine-rich antifungal peptide ToAMP4 from Taraxacum officinale Wigg. flowers. Plant Physiol Biochem (2013) 0.76

[Fatty acid constitution of the lachrymal fluid in healthy subjects and in patients with ophthalmopathology]. Klin Lab Diagn (2005) 0.76

[Artificial blood--a new stage in the development of current transfusiology]. Probl Gematol Pereliv Krovi (1982) 0.75

[Acute toxicity of the antihelminthic mitranox]. Med Parazitol (Mosk) (2015) 0.75

[Fractionation of nonionogenic surface-active substances]. Probl Gematol Pereliv Krovi (1982) 0.75

[Preservation of an isolated kidney in normothermic conditions by perfluorotributylamine emulsion perfusion]. Biull Eksp Biol Med (1983) 0.75

[Experimental study of the cumulative properties of the new drug mitranox]. Med Parazitol (Mosk) (2014) 0.75

[Elimination of perfluoro-organic compounds from rat organs]. Gematol Transfuziol (1983) 0.75

[Angioneurotic edema of the face and upper extremities]. Zh Nevropatol Psikhiatr Im S S Korsakova (1991) 0.75

[Body's oxygen supply after total blood substitution with organofluoric emulsions]. Gematol Transfuziol (1983) 0.75

[Biological properties of emulsions of organofluorine compounds as model oxygen-carrier blood substitutes]. Probl Gematol Pereliv Krovi (1979) 0.75

[Structural Features of Cysteine-Stabilized Polypeptides from Sea Anemones Venoms]. Bioorg Khim (2016) 0.75

[Perfusion of the isolated heart using ftoksilol, an emulsion of perfluorocarbons]. Biull Eksp Biol Med (1982) 0.75

[Optimal anion composition of the perfusate for preservation of the liver]. Vestn Khir Im I I Grek (1986) 0.75

[Determination of fluorocarbons in organs by gas chromatography]. Probl Gematol Pereliv Krovi (1982) 0.75

[Comparative evaluation of thrombelastogram indices during testing of the emulsifying agents of perfluoroorganic compounds]. Gematol Transfuziol (1987) 0.75

[Optimal setup for liver perfusion]. Khirurgiia (Mosk) (1982) 0.75

[State of the microcirculation following total blood replacement with a model perfluorotributylamine-based blood substitute in rats]. Biull Eksp Biol Med (1980) 0.75

[The Biological Activity of the Sevanol and Its Analogues]. Bioorg Khim (2016) 0.75

[Pathogenetic validation of xidiphone use in combined therapy for periodontal diseases]. Stomatologiia (Mosk) (2002) 0.75

[Elimination of perfluorides of different classes with exhaled air after infusion of emulsions prepared on their base]. Gematol Transfuziol (1983) 0.75

[Changes in lipid metabolism in acute postpartum hemorrhage]. Akush Ginekol (Mosk) (1984) 0.75

[Effect of the anthelmintic nadinate on rat serum hematological and biochemical parameters in the subchronic experiment]. Med Parazitol (Mosk) (2016) 0.75

[Hematopoietic study of rats in experiments with exchange blood replacement by an emulsion of perfluorotributylamine]. Biull Eksp Biol Med (1979) 0.75

[Role of glycolysis and fumarate reduction to succinate in the mechanism of adaptation of the body to hypoxia in mammals]. Kosm Biol Aviakosm Med (1978) 0.75

[Monthly dynamics of the epidemic process in viral hepatitis B]. Zh Mikrobiol Epidemiol Immunobiol (1988) 0.75

[Rate of basic energetic processes in the individual organs and the resistance of animals to severe blood loss]. Patol Fiziol Eksp Ter (1978) 0.75

[Changes in lactate dehydrogenase activity and lactic and pyruvic acid concentration in the blood and tissues of animals following intravenous administration of perfluorotributylamine emulsions]. Vopr Med Khim (1981) 0.75

[Stimulation of the rate of lactate utilization by the liver during long-term fasting as a factor in increasing resistance to hypoxic hypoxia]. Patol Fiziol Eksp Ter (1986) 0.75

[Treatment of patients with trigeminal neuralgia by xidifon electrophoresis]. Zh Nevropatol Psikhiatr Im S S Korsakova (1990) 0.75

Secure polarization-independent subcarrier quantum key distribution in optical fiber channel using BB84 protocol with a strong reference. Opt Express (2016) 0.75

[State of circulation and the body's oxygen supply following total blood replacement with perfluorotributylamine emulsion]. Biull Eksp Biol Med (1980) 0.75

[Effect of elemental nutrition and fasting on the resistance of the liver to ischemia]. Vestn Khir Im I I Grek (1987) 0.75

[Adaptation to hypoxia as a factor enhancing work capacity]. Vestn Ross Akad Med Nauk (1997) 0.75

[Effects of complex therapy with emoxipin on the course of diabetic retinopathy]. Vestn Oftalmol (2003) 0.75

[Use of thoracic duct lymph for early detection of hepatic failure in the postresuscitation period]. Anesteziol Reanimatol (1986) 0.75

[Development of an optimal perfusion solution for liver preservation at temperatures of 2-4 degrees C]. Vestn Khir Im I I Grek (1981) 0.75

[Pharmacological protection of the liver from ischemia]. Anesteziol Reanimatol (1988) 0.75

[Kinetics of oxygen saturation of fluorocarbon emulsions]. Vopr Med Khim (1981) 0.75

[Cyclic fasting as a factor of higher body resistance to acute lymphoid leukemia]. Gematol Transfuziol (1996) 0.75

[Hazards and complications of endoscopic transurethral ureterolithotripsy and lithoextraction and means of prevention]. Urol Nefrol (Mosk) (1989) 0.75

[Bladder neck sclerosis in children]. Urol Nefrol (Mosk) (1990) 0.75

[Comparative evaluation of the thromboelastogram indices in in vitro research on emulsions of perfluoro-organic compounds]. Gematol Transfuziol (1987) 0.75

[Organofluorine compounds as oxygen-carrier blood substitutes]. Probl Gematol Pereliv Krovi (1979) 0.75

[Spread of intestinal infections and invasions in relation to population migration]. Tr Inst Im Pastera (1982) 0.75

Experimental substantiation of the efficiency of antioxidant therapy for post-traumatic arthritis. Bull Exp Biol Med (2013) 0.75

[The pathogenetic therapy of Raynaud's syndrome]. Zh Nevrol Psikhiatr Im S S Korsakova (1996) 0.75

[Anti-ischemic protection of the liver using perfluorocarbon emulsion]. Gematol Transfuziol (1989) 0.75

[Use of donor albumin and polyglucin as hemodynamic ingredients in perfluorocarbon emulsions]. Gematol Transfuziol (1984) 0.75

[Optimal method of liver perfusion with saline solution under moderate hypothermia]. Anesteziol Reanimatol (1984) 0.75

[Dynamics of arterial pressure and gas exchange in dogs with acute blood loss replaced by an emulsion of carbon tetrafluoride]. Gematol Transfuziol (1983) 0.75

[Optimal cationic composition of perfusates in relation to temperature during preservation of the liver]. Vestn Khir Im I I Grek (1985) 0.75

[Russian preparations for the metabolic therapy of multiple sclerosis patients]. Zh Nevrol Psikhiatr Im S S Korsakova (1995) 0.75

[Embryotoxic properties of the Russian anthelmintic nadinate]. Med Parazitol (Mosk) (2016) 0.75

[Gas chromatographic method of determining polydispersion in the staged centrifugation of perfluoro compound emulsions as bases for a complex oxygen-carrier blood substitute]. Probl Gematol Pereliv Krovi (1982) 0.75

[Gas exchange and blood circulation status in dogs following replacement of acute blood loss by perfluoro compound emulsions]. Biull Eksp Biol Med (1983) 0.75

Generation of high-intensity spectral supercontinuum of more than two octaves in a water jet. Appl Opt (2016) 0.75

[Effect of polyglucin and gelatinol additions to Hanks' perfusion solution on the function of the isolated rabbit liver]. Anesteziol Reanimatol (1980) 0.75

[Effect of fasting and elemental carbohydrate feeding on the liver resistance to the action of cytostatics]. Gematol Transfuziol (1990) 0.75

[Sexual activity of patients with prostatic adenoma]. Urol Nefrol (Mosk) (1985) 0.75

[Effectiveness of total body washout in acute medinal poisoning]. Anesteziol Reanimatol (1984) 0.75

[Microcirculatory indices in the experimental therapy of acute blood loss using a blood substitute--an oxygen carrier based on perfluorodecalin]. Gematol Transfuziol (1983) 0.75

[Anti-arrhythmic action of a carbon tetrafluoride emulsion]. Biull Eksp Biol Med (1982) 0.75

[Mechanisms of formation of chronic low back pain relapse and their correction in patients with dorsopathy]. Zh Nevrol Psikhiatr Im S S Korsakova (2008) 0.75

[Synthetic analogues of antimicrobial peptides from the venom of the Central Asian spider Lachesana tarabaevi]. Bioorg Khim (2007) 0.75

[Changes in lipid metabolism and phosphatase activity in late pregnancy toxemia]. Akush Ginekol (Mosk) (1986) 0.75

[Effectiveness of a series of pharmacological substances in liver ischemia]. Vopr Med Khim (1991) 0.75

[Non-ionogenic surface-active agents as a component of oxygen carrying fluorocarbon blood substitutes]. Probl Gematol Pereliv Krovi (1982) 0.75

[Preparations for parenteral nutrition as agents increasing resistance to hypoxia]. Gematol Transfuziol (1986) 0.75

[Antileukemic activity of liposome forms of cytosine arabinoside and cyclocytidine]. Gematol Transfuziol (1984) 0.75

[The use of xidifon in the vertebral artery syndrome during exacerbation]. Zh Nevropatol Psikhiatr Im S S Korsakova (1991) 0.75

[Transurethral endoscopic ureterolithotripsy]. Urol Nefrol (Mosk) (1987) 0.75

[Comparative study of various biochemical and physiological parameters of isolated perfused liver of rabbits, guinea pigs and rats]. Vopr Med Khim (1987) 0.75

[An epidemiological assessment of the chronic carriage of the hepatitis B virus surface antigen and other markers of this infection]. Zh Mikrobiol Epidemiol Immunobiol (1991) 0.75

Adjuvant effect of high-frequency hyperthermia of the abdominal cavity on the course of transplanted leukemia in AKR mice. Bull Exp Biol Med (2004) 0.75

[Study of the effectiveness of blood substitution in acute lethal hemorrhage with polyglucin and polyglucin with the ionic composition of Hanks' solution]. Probl Gematol Pereliv Krovi (1977) 0.75

[Effect of anti-ischemic protection on biochemical indices of the isolated perfused liver]. Vopr Med Khim (1988) 0.75

[Increase in the rate of anaerobic glycolysis as an index of hypoxia in hemorrhagic shock]. Vopr Med Khim (1977) 0.75

[Changes in the indices of carbohydrate-phosphorus metabolism in women with acute hemorrhage during labor management]. Akush Ginekol (Mosk) (1983) 0.75

[Elemental nutrition and fasting as means for the ischemic protection of the liver]. Patol Fiziol Eksp Ter (1988) 0.75

[The clinical and diagnostic value of tear fluid studies (review of literature)]. Klin Lab Diagn (2005) 0.75

[Fluorocarbons as possible oxygen-carrying blood substitutes]. Probl Gematol Pereliv Krovi (1981) 0.75